Suppr超能文献

[泌尿生殖系统放射学中的造影剂]

[Contrast media in urogenital radiology].

作者信息

Foschi N, Totaro A, Brescia A, Gulino G, Bassi P F

出版信息

Urologia. 2009 Jan-Mar;76(1):10-8.

Abstract

BACKGROUND. Contrast media are widely used in urogenital radiology. The ideal contrast agent should be totally inert, causing no interactions with organism, and with a rapid and complete excretion. Adverse reactions could occur after using any type of contrast media. Contrast enhanced procedures are performed with increasing frequency and the patients population is progressively older and with multiple co-morbid conditions, thus contrast media toxicity is becoming a serious problem. Contrast media-induced nephropathy (CIN) is considered an important cause of hospital-acquired renal failure. The administration of gadolinium-based contrast agents has been recently associated with the development of a serious adverse reaction, potentially lethal in patients with renal insufficiency, named nephrogenic systemic fibrosis (NSF). METHODS. Literature review on contrast media in urogenital radiology, CIN, NSF. CONCLUSIONS. Since 1996, the Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) has released its guidelines regarding safety about the use of contrast media. CIN, and the emerging NSF, are topics of increasing interest for urologists, radiologists, nephrologists, dermatologists and all the clinicians. Contrast media have progressively become safer in the last years. Even if rare, some adverse reactions still occurr up to now. CIN and its prevention remain an issue under debate. In the past, whenever a patient required a contrast-enhanced imaging study, the trend was to select magnetic resonance imaging with gadolinium-based contrast agents in order to avoid the well-known CIN of iodinated-based contrast agents. The awareness of NFS is changing the contrast-enhanced imaging in patients with renal failure. At present we have to investigate NSF etiopathogenesis, in order to prevent and eventually to cure it. The understanding of the risk factors for both CIN and NSF is an emerging need, the adoption of all preventive measures to reduce the risks remain a mandatory issue.

摘要

背景。造影剂在泌尿生殖系统放射学中被广泛使用。理想的造影剂应完全惰性,不与机体发生相互作用,并能快速、完全排泄。使用任何类型的造影剂后都可能发生不良反应。造影增强检查的频率越来越高,患者群体日益老龄化且合并多种疾病,因此造影剂毒性正成为一个严重问题。造影剂诱发的肾病(CIN)被认为是医院获得性肾衰竭的重要原因。基于钆的造影剂的使用最近与一种严重不良反应的发生有关,这种反应对于肾功能不全患者可能是致命的,即肾源性系统性纤维化(NSF)。方法。对泌尿生殖系统放射学中的造影剂、CIN、NSF进行文献综述。结论。自1996年以来,欧洲泌尿生殖系统放射学会(ESUR)的造影剂安全委员会已发布关于造影剂使用安全的指南。CIN以及新出现的NSF,正成为泌尿科医生、放射科医生、肾科医生、皮肤科医生及所有临床医生越来越关注的话题。在过去几年中,造影剂已逐渐变得更安全。即便不良反应至今仍有发生,但已较为罕见。CIN及其预防仍是一个有争议的问题。过去,每当患者需要进行造影增强成像检查时,为避免碘造影剂所致的众所周知的CIN,倾向于选择使用基于钆的造影剂的磁共振成像。对NFS的认识正在改变肾衰竭患者的造影增强成像。目前我们必须研究NSF的病因发病机制以预防并最终治愈它。了解CIN和NSF的危险因素是新出现的需求,采取所有预防措施以降低风险仍是一个必须解决的问题。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验